Maggie is a lead editor for The American Journal of Managed Care® (AJMC®), AJMC.com, and Evidence-Based Oncology, for which she produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and she has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
The pandemic has exacerbated not only cardiovascular care, but also the mental health of patients, noted Mariana Garcia, MD, cardiology fellow in the Academic Clinical Investigator Pathway at Emory University and member of T32, Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health (METRIC).
The cumulative effects of binge drinking and HIV on neurocognitive functioning were investigated among 4 groups of patients in this recent study from researchers at San Diego State University and the University of California San Diego.
People living with HIV have known greater rates of stroke, but the reason for that risk was the focus of an abstract presented last week at IAS 2021, this year's virtual annual meeting of the International AIDS Society, which took place July 18 to 21.
We do not yet know the exact mechanism of action of sodium glucose co-transporter-2 (SGLT2) inhibitors in heart failure (HF), but there are many exciting pssibilities, stated Clyde W. Yancy, MD, MSc, of Northwestern University’s Feinberg School of Medicine.
Providers need to put themselves in their patients' shoes and think about how they would like to receive services, emphasized Helen Bygrave, MD, chronic diseases advisor for the Médecins Sans Frontières’ (Doctors Without Borders) Access Campaign.
An abstract presented at IAS 2021, this year's virtual annual meeting of the International AIDS Society, addressed health care disparities that persist among persons living with HIV, with the ultimate goal being to improve health equity for this patient population.
Inconsistent application and measure of the Kidney Disease Improving Global Outcomes definition of acute kidney injury (AKI) prompted this review, which used a measure of 75% agreement when defining consensus.
Patients should continue to be monitored while on treatment with SGLT2 inhibitors if they are being treated for comorbid type 2 diabetes and heart failure, emphasized Mikhail N. Kosiborod, MD, cardiologist, vice president of Research at Saint Luke's Health System.
Adults living with HIV sometimes get lost, and we need to optimize their outcomes, noted Allison Agwu, MD, ScM, FAAP, FIDSA, Johns Hopkins University School of Medicine.
This new study from Japan investigated possible relationships between tubular injury, COVID-19 severity, and inflammatory markers with development of acute kidney injury.
The characteristics of the tumor and the presence of surgical fatigue can help determine patients’ candidacy for skin cancer surgery, explained Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.
By 2020, UNAIDS had hoped to meet the 90-90-90 goal it originally set in 2014: to have 90% of people living with HIV know their status, 90% be on antiretroviral therapy (ART), and 90% have achieved viral suppression. The world fell short of meeting that goal, with just 81% knowing their positive status, two-thirds on ART, and 59% being virally suppressed.
According to this retrospective analysis of preexposure prophylaxis (PrEP) utilization rates in the United States, fewer than 20% of indicated users are taking the HIV preventive medication.
Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy.
This new study from Spain represents the first extensive look at late presentation of persons living with HIV, following the 2014 introduction of guidelines on early HIV diagnosis.
Data from several surveys conducted since 2005 indicate a continuous gap in HIV prevention and transmission between adolescent females and males in sub-Saharan Africa.
Statin use benefited individuals with heart failure by lowering their cancer-related risks, both of developing any cancer at all and of dying from the comorbid condition.
Originally set to expire on June 30, 2021, the Oncology Care Model was extended for an additional year in light of the COVID-19 pandemic.
Research that will be presented at Heart Failure 2021 shows patients with heart failure may have a greater incidence of several types of cancer and that this chance is even higher in women vs men.
The Supreme Court recently upheld the Affordable Care Act, under which HIV and AIDS are considered preexisting conditions, by a vote of 7 to 2.
Despite gains in HIV testing rates among individuals 13 years and older, total testing rates remain at suboptimal levels among both commercial insurance and Medicaid beneficiaries.
Survey responses from the San Francisco Bay Area, from men who have sex with men (MSM), show differing behavioral and social influences on the risk of sexually transmitted infections (STIs).
Early intensive treatment was more efficacious at slowing disease accumulation in patients with relapsing-remitting multiple sclerosis (RRMS) vs initiating therapy with a moderate-efficacy disease-modifying treatment (DMT) prior to switching to a higher-efficacy DMT.
As a specialized health care service, telemedicine was shown to be comparable to traditional care for persons living with HIV in rural Georgia.
Compared with individuals without known HIV infection, persons living with HIV had higher rates of sudden cardiac death and increased interstitial myocardial fibrosis in a new New England Journal of Medicine study.
Out-of-pocket (OOP) spending for patients with heart failure with reduced ejection fraction rose in the event of a worsening heart failure event across the 4 phases of Medicare Part D coverage.
The study authors hope their findings inform future interventions whose goal is to minimize the comorbidity burden of adults with multiple sclerosis (MS), thereby improving their quality of life and ultimate health outcomes.
Results from 2 studies presented at this year’s European Hematology Association meeting demonstrate the long-term tolerability and efficacy of the Bruton tyrosine kinase inhibitor.
Compared with their peers receiving injectable treatments for their relapsing-remitting multiple sclerosis (RRMS), children who received newer disease-modifying therapies (DMTs) had improved scores on several measures of disease progression.
Progressive rehabilitation produced superior results among patients randomized to a 36-session program during or following hospitalization for acute decompensated heart failure vs those randomized to usual care.
